Friedland Jeffrey 4
4 · NEXIEN BIOPHARMA, INC. · Filed Nov 25, 2019
Insider Transaction Report
Form 4
Friedland Jeffrey
Other
Transactions
- Gift
Common Stock
2019-11-22−833,333→ 0 total - Gift
Common Stock
2019-11-22−228,800→ 0 total(indirect: By LLC)
Holdings
- 19,000,000(indirect: By Kanativa USA Inc.)
Common Stock
[F1]
Footnotes (1)
- [F1]The Reporting Person disclaims all beneficial ownership of the securities owned by Kanativa USA Inc., and this report shall not be deemed an admission of beneficial ownership of such securities by the Reporting Person.
Signature
/s/ Jeffrey Friedland|2019-11-25